問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

劉安祥
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2026-01-01 - 2030-12-31

Phase I/II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2023-08-01 - 2027-04-30

Phase I/II

Active
A Phase Ib/II, Open-label Study of NBM-BMX as Monotherapy or in Combination with Radiotherapy and Temozolomide in Subjects with Solid Tumors or Newly Diagnosed Glioblastoma
  • Condition/Disease

    Newly Diagnosed Glioblastoma

  • Test Drug

    NBM-BMX

Participate Sites
4Sites

Recruiting4Sites

2023-08-01 - 2027-04-30

Phase I/II

A Phase Ib/II, Open-label Study of NBM-BMX As Monotherapy or in Combination with Radiotherapy and Temozolomide in Subjects with Solid Tumors or Newly Diagnosed Glioblastoma
  • Condition/Disease

    Newly Diagnosed Glioblastoma

  • Test Drug

    NBM-BMX

Participate Sites
5Sites

Not yet recruiting2Sites

Recruiting3Sites